LDL from patients with well-controlled IDDM is not more susceptible to in vitro oxidation

Diabetes

Volumn 45, Issue 6, 1996, Pages 762-767

  Jenkins, Alicia J ^a   Klein, Richard L ^a   Chassereau, Charlyne N ^a   Hermayer, Kathie L ^a   Lopes Virella, Maria F ^a  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GLYCATION; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LIPID COMPOSITION; LIPID OXIDATION; MALE; PRIORITY JOURNAL;

EID: 0029887385     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.45.6.762     Document Type: Article

References (53)

1. Kannel WB, McGee DL: Diabetes and cardiovascular disease: the Framingham Study. Diabetes 241:2035-2038, 1979
2. Brown VW: Lipoprotein disorders in diabetes mellitus. Med Clin North Am 78:143-161, 1994
3. Jenkins A, Best J: The role of lipoprotein(a) in the vascular complications of diabetes mellitus. J Intern Med 237:359-365, 1995
4. Lyons TJ: Oxidized LDL: A role in the pathogenesis of atherosclerosis in diabetes? Diabetic Med 8:411-419, 1991
5. Baynes JW: The role of oxidative stress in the development of complications in diabetes. Diabetes 40:405-412, 1991
6. Lopes-Virella MF, Klein RL, Virella G: Modification of lipoproteins in diabetes. Diabetes Metab Rev. In press
7. Steinberg D: Modified forms of LDL and atherogenesis. J Intern Med 233:227-232, 1993
8. Witztum JL: Role of oxidized LDL in atherogenesis. Br Heart J 69 (Suppl. 1):S12-S18, 1993
9. Chisolm GM, Irwin KC, Penn MS: Lipoprotein oxidation and lipoprotein induced cell injury in diabetes. Diabetes 41 (Suppl. 2):61-66, 1992
10. Mullarkey CJ, Edelstein D, Brownlee M: Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 173:932-939, 1990
11. Ghiselli A, Laurenti O, DeMattia, Maiani G, Ferro-Luzzi A: Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients. Free Radical Biol Med 13:621-626, 1992
12. Strain JJ: Disturbances of micronutrient and antioxidant status in diabetes. Proc Nutr Soc 50:591-604, 1991
13. Asayama K, Uchida N, Nakane T, Hayashibe H, Dobashi, Amemiya A, Kato K, Nakazawa S: Antioxidants in the serum of children with IDDM. Free Radical Biol Med 15:597-602, 1993
14. Regnström J, Nilsson J, Tornvall P, Landou C, Hamsten A: Susceptibility to LDL oxidation and coronary atherosclerosis in man. Lancet 339:1183-1186, 1992
15. Chiu H-C, Jeng J-R, Shieh S-M: Increased oxidizability of plasma low density lipoprotein from patients with coronary atherosclerosis in man. Biochim Biophys Acta 1225:200-208, 1994
16. Andrews B, Burnand K, Paganga G, Browse N, Rice-Evans C, Sommerville K, Leake D, Taub N: Oxidisability of low density lipoproteins in patients with carotid or femoral artery atherosclerosis. Atherosclerosis 112:77-84, 1995
17. Tsai EC, Hirsch IB, Brunzell JD, Chait A: Reduced plasma peroxy radical trapping capacity and increased susceptibility of LDL to oxidation in poorly controlled IDDM. Diabetes 43:1010-1014, 1994
18. Chung BH, Segrest JR, Ray MJ, Brunzell JD, Hokansen JE, Krauss RM, Beaudrie K, Cone JT: Single vertical spin density gradient ultracentrifugation: plasma lipoproteins: preparation, structure and molecular biology. Methods Enzymol 128:181-209, 1986
19. Esterbauer H, Striel G, Puhl H, Rotheneder M: Continuous monitoring of in vitro oxidation of low density lipoprotein. Free Radical Res Commun 6:67-75, 1989
20. Jenkins A, Chassereau C, Klein R, Lopes-Virella M: In vitro LDL oxidizability is not increased in patients with well controlled IDDM (Abstract). Diabetes 44 (Suppl. 1):43A, 1995
21. Klein RL, Wohltmann HJ, Lopes-Virella MF: Influence of glycemic control on interaction of very-low- and low-density lipoproteins isolated from type 1 diabetic patients with human monocyte-derived macrophages. Diabetes 41:1301-1307, 1992
22. Lyons TJ, Klein RL, Baynes JW, Lopes-Virella MF: Stimulation of cholesteryl ester synthesis in human monocyte derived macrophages by LDL from type 1 diabetic patients: the influence of non-enzymatic glycation of low density lipoprotein. Diabetologia 30:916-823, 1987
23. Morel DW, Hessler JR, Chisolm GM: Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. J Lipid Res 24:1070-1076, 1983
24. Klein RL, Rudel LL: Effect of dietary cholesterol level on the composition of thoracic duct lymph lipoproteins isolated from nonhuman primates. J Lipid Res 24:357-367, 1983
25. Spector AA, Kiser RE, Denning GM, Hoh SWM, DeBault LE: Modification of the fatty acid composition of cultured human fibroblasts. J Lipid Res 20:536-547, 1979
26. Parks JS, Gebre AK: Studies on the effect of dietary fish oil on the physical and chemical properties of low density lipoproteins in cynomologus monkeys. J Lipid Res 32:305-315, 1981
27. Bowie A, Owens D, Collins P, Johnson A, Tomkin G: Glycosylated LDL is more sensitive to oxidation: implications for the diabetic patient? Atherosclerosis 102:63-67, 1993
28. Babiy AV, Gebicki JM, Sullivan DR, Wiley K: Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol and is not due to glycation. Biochem Pharmacol 43:995-1000, 1992
29. Curtiss LK, Witztum JL: Plasma apolipoproteins A-I, A-II, B, C-I and E are glucosylated in hyperglycemic diabetic subjects. Diabetes 34:452-461, 1985
30. Witztum JL, Mahoney EM, Branks MJ, Fisher M, Elam R, Steinberg D: Nonenzymatic glucosylation of low-density lipoprotein alters its biologic activity. Diabetes 33:283-291, 1982
31. Sasaki J, Cottam GL: Glycation of LDL decreased its ability to interact with high-affinity receptors of human fibroblasts in vitro and decreases its clearance from rabbit plasma in vivo. Biochim Biophys Acta 713:199-207, 1982
32. Lopes-Virella MF, Sherer GK, Lees AM, Wohltmann H, Mayfield R, Sagel J, Leroy EC, Colwell JA: Surface binding, internalization and degradation by cultured human fibroblasts of low density lipoproteins isolated from type 1 (insulin-dependent) diabetic patients: changes with metabolic control. Diabetologia 22:430-436, 1982
33. Klein RL, Laimins M, Lopes-Virella MF: Isolation, characterization and metabolism of the glycated and non-glycated subfractions of low density lipoproteins isolated from type 1 diabetic patients and non-diabetic subjects. Diabetes 44:1093-1098, 1995
34. Hunt JV, Smith CCT, Wolf SP: Autooxidative glycation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39:1420-1424, 1990
35. 2 radical generation by Maillard compounds. J Diabetic Complications 2:19-21, 1988
36. Gillery P, Monboisse JC, Maquart FX, Borel JP: Glycation of proteins as a source of superoxide. Diabetes Metab Rev 14:25-30, 1988
37. Mullarkey CJ, Edelstein D, Brownlee M: Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes. Biochem Biophys Res Commun 177:932-939, 1990
38. Sakurai T, Kimura S, Nakano M, Kimura H: Oxidative modification of glycated low density lipoprotein in the presence of iron. Biochem Biophys Res Commun 177:433-439, 1991
39. Kawamura M, Heinecke JW, Chait A: Pathophysiological concentrations of glucose promote oxidative modification of LDL by a superoxide-dependent pathway. J Clin Invest 94:771-778, 1994
40. Esterbauer H, Dieber-Rotheneder M, Waeg G, Striegl G, Jürgens G: Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol 3:77-92, 1990
41. Esterbauer H, Rotheneder M, Striegl G, Waeg G, Ashy A, Slattler W, Jürgens G: Vitamin E and other lipophilic antioxidants protect LDL against oxidation. Fat Sci Technol 91:316-324, 1989
42. Parthasarathy S, Khoo JC, Miller E, Barnett J, Witztum J, Steinberg D: Low density lipoprotein rich in oleic acid is protected against oxidative modification: implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci USA 87:3894-3898, 1990
43. Thomas MJ, Thornburg T, Manning J, Hooper K, Rudel LL: Fatty acid composition of low-density lipoprotein influences its susceptibility to autoxidation. Biochemistry 33:1828-1834, 1094
44. deGraf J, Hak-Lemmers HLM, Hectors MPC, Demacker PNM, Hendriks JCM, Stalenhoef AFH: Enhanced susceptibility to in vitro oxidation of the dense low density lipoprotein subfraction in healthy subjects. Arterioscler Thromb 11:298-306, 1991
45. Chait A, Brazg RL, Tribble DL, Krauss RM: Susceptibility of small, dense, low-density lipoproteins to oxidative modification in subjects with the atherogenic lipoprotein phenotype, pattern B. Am J Med 94:350-356, 1993
46. Maggi E, Chiesa R, Melissano G, Castellano R, Astore D, Grossi A, Finardi G, Bellomo G: LDL oxidation in patients with severe carotid atherosclerosis: a study of in vitro and in vivo oxidation markers. Arterioscler Thromb 14:1892-1899, 1994
47. Kleinveld HA, Hak-Lemmers HLM, Hectors MPC, de Fouw NJ, Demacker PNM, Stalenhoef AFH: Vitamin E and fatty acid intervention does not attenuate the progression of atherosclerosis in Watanabe heritable hypelipidemic rabbits. Arterioscler Thromb Vasc Biol 15:290-297, 1995
48. Kleinveld HA, Demacker PNM, Stalenhoef AFH: Comparative study on the effect of low dose vitamin E and probucol on the susceptibility of LDL to oxidation and the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbits. Arterioscler Thromb 14:1386-1391, 1994
49. Fruebis J, Steinberg D, Dresel HA, Carew TE: A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density receptor-deficient rabbits. J Clin Invest 94:392-398, 1994
50. Sasahara M, Raines EW, Chait A, Carew T, Steinberg D, Wahl PW, Ross R: Inhibition of hypercholesterolemia-induced atherosclerosis in the nonhuman primate by probucol. I. Is the extent of atherosclerosis related to resistance of LDL to oxidation? J Clin Invest 94:155-164, 1994
51. Shaish A, Daugherty A, O'Sullivan F, Schonfield G, Heinecke JW: Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J Clin Invest 96:2075-2082, 1995
52. Parker RA, Sabrah T, Cap M, Gill BT: Relation of vascular oxidative stress, α-tocopherol, and hypercholesterolemia to early atherosclerosis in hamsters. Arteriosrler Thromb Vasc Biol 15:349-1358, 1995
53. Nunes GL, Sgoutas DS, Redden RA, Sigman SR, Gravanis MB, King SB, Berk BC: Combination of vitamins C and E alters the response to coronary balloon injury in the pig. Arterioscler Thromb Vasc Biol 15:156-165, 1995